» Articles » PMID: 37296099

Xylosyltransferase I Mediates the Synthesis of Proteoglycans with Long Glycosaminoglycan Chains and Controls Chondrocyte Hypertrophy and Collagen Fibers Organization of in the Growth Plate

Overview
Journal Cell Death Dis
Date 2023 Jun 9
PMID 37296099
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic mutations in the Xylt1 gene are associated with Desbuquois dysplasia type II syndrome characterized by sever prenatal and postnatal short stature. However, the specific role of XylT-I in the growth plate is not completely understood. Here, we show that XylT-I is expressed and critical for the synthesis of proteoglycans in resting and proliferative but not in hypertrophic chondrocytes in the growth plate. We found that loss of XylT-I induces hypertrophic phenotype-like of chondrocytes associated with reduced interterritorial matrix. Mechanistically, deletion of XylT-I impairs the synthesis of long glycosaminoglycan chains leading to the formation of proteoglycans with shorter glycosaminoglycan chains. Histological and Second Harmonic Generation microscopy analysis revealed that deletion of XylT-I accelerated chondrocyte maturation and prevents chondrocytes columnar organization and arrangement in parallel of collagen fibers in the growth plate, suggesting that XylT-I controls chondrocyte maturation and matrix organization. Intriguingly, loss of XylT-I induced at embryonic stage E18.5 the migration of progenitor cells from the perichondrium next to the groove of Ranvier into the central part of epiphysis of E18.5 embryos. These cells characterized by higher expression of glycosaminoglycans exhibit circular organization then undergo hypertrophy and death creating a circular structure at the secondary ossification center location. Our study revealed an uncovered role of XylT-I in the synthesis of proteoglycans and provides evidence that the structure of glycosaminoglycan chains of proteoglycans controls chondrocyte maturation and matrix organization.

Citing Articles

mRNA Degradation as a Therapeutic Solution for Mucopolysaccharidosis Type IIIC: Use of Antisense Oligonucleotides to Promote Downregulation of Heparan Sulfate Synthesis.

Santos J, Goncalves M, Almeida M, Rocha H, Duarte A, Matos L Int J Mol Sci. 2025; 26(3).

PMID: 39941041 PMC: 11818647. DOI: 10.3390/ijms26031273.


Xylosyltransferase-Deficiency in Human Dermal Fibroblasts Induces Compensatory Myofibroblast Differentiation and Long-Term ECM Reduction.

Kleine A, Kuhle M, Ly T, Schmidt V, Faust-Hinse I, Knabbe C Biomedicines. 2024; 12(3).

PMID: 38540185 PMC: 10967791. DOI: 10.3390/biomedicines12030572.


Targeting FGFR3 signaling and drug repurposing for the treatment of SLC26A2-related chondrodysplasia in mouse model.

Li P, Wang D, Lu W, He X, Hu J, Yun H J Orthop Translat. 2024; 44:88-101.

PMID: 38282752 PMC: 10818158. DOI: 10.1016/j.jot.2023.09.003.

References
1.
Melrose J, Shu C, Whitelock J, Lord M . The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation. Matrix Biol. 2016; 52-54:363-383. DOI: 10.1016/j.matbio.2016.01.008. View

2.
Muir H . Proteoglycans of cartilage. J Clin Pathol Suppl (R Coll Pathol). 1978; 12:67-81. PMC: 1347125. View

3.
Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet J, Maroteaux P . Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994; 371(6494):252-4. DOI: 10.1038/371252a0. View

4.
Kozhemyakina E, Lassar A, Zelzer E . A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development. 2015; 142(5):817-31. PMC: 4352987. DOI: 10.1242/dev.105536. View

5.
Rojas F, Batista M, Lindburg C, Dean D, Grodzinsky A, Ortiz C . Molecular adhesion between cartilage extracellular matrix macromolecules. Biomacromolecules. 2014; 15(3):772-80. PMC: 3983133. DOI: 10.1021/bm401611b. View